ATTORNEYS & STAFF

Few industries have seen – or are poised for – more significant economic growth and impact than women’s health. Since its rapid evolution began, Delphine O’Rourke, JD, has been an essential advocate, central resource, and key supporter for women’s health organizations, offering her singular expertise in healthcare & wellness, law & policy, and innovation.

A globally recognized expert in women’s health, she partners with innovative teams and businesses to help create high impact solutions at scale. She is Founder and Chair of the Women’s Health Industry practice group at Bochner Law – the only legal team dedicated to the sector, its laws, and public policy directly impacting the industry. 

As growth in the women’s health industry continues to accelerate, Delphine’s deep experience in the field makes her uniquely able to address the full array of legal issues confronting healthcare companies of all sizes and every stage of development. A trusted legal advisor to institutional investors, employers, health systems, providers, and entrepreneurs, her reputation for passion and commitment to the industry continues to grow.

Delphine’s tireless advocacy and search for ways to advance the healthcare industry led her to build the first global legal practice focused on women’s health and wellness industry as a partner with Goodwin. 

Prior to Goodwin, Delphine was Associate General Counsel of Ascension – one of the largest nonprofit health systems in the United States (nearly $30 billion in revenue), which operates more than 2,600 health care sites in 19 states and Washington, D.C., including 142 hospitals and 40 senior living facilities.

Widely recognized for her professional achievements, she is regularly named one of the nation’s top Health Care Law practitioners by Best Lawyers in America® and was nominated by the Financial Times for its 2023 awards honoring the most innovative lawyer and most innovative legal practice. Delphine is an Adjunct Professor at Columbia Law School and a sought-after speaker on healthcare innovation, women’s health, and the impact of healthcare policy and regulation on industry.